Screening of Immunized Rabbit Antibody Library

본문 바로가기


Home > Product > Screening of Immunized Rabbit Antibody Library
Product
Screening of Immunized Rabbit Antibody Library
Posting date : Jul 11, 2017
Membership
Free Member Scince Nov 07, 2012
FOB Price
1
Min. Order Quantity
1
Supply Abillity
1
Port
1
Payment Terms
1
Package
1
Keyword :
Category
Contact
Bella Smith
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
United States [US]
Brand Name
Creative Biolabs
HS-CODE
3002-10
Package & Delivery Lead Time
Package
1
Detailed Description
Selection of high affinity binders is mainly based on the in-solution phage display antibody library screening strategies we employ. We have two strategies: selection based on the equilibrium constant (Kd) and selection based on binding kinetics. In the first approach, sub-library phage is incubated with biotinylated antigen at controlled concentrations and bound phages are captured by immobilized NeutrAvidin. The second, selection based on binding kinetics is also termed off-rate (Koff) selection, in which phage population is allowed to saturate the labeled antigen before a large molar excess of unlabeled antigen is added to the mix for controlled periods of time. This allows the selection of mutant antibodies that have slower off-rates. Since a reduction in Koff usually results in a higher affinity, this selection approach singles out antibody variants with improved Kd. These methods allow selection of antibodies that have high affinity. In the end, the selected antibody fragments can be expressed to test their binding specificity and affinity.More information, please visit the website: http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top